CWM
MDT icon

Concentric Wealth Management’s Medtronic MDT Stock Holding History

Concentric Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.69M Sell
29,920
-1,127
-4% -$94.8K 0.66% 57
2024
Q2 		$2.44M Buy
31,047
+1,105
+4% +$90.6K 0.64% 56
2024
Q1 		$2.61M Buy
29,942
+1,249
+4% +$107K 0.69% 55
2023
Q4 		$2.36M Buy
28,693
+2,280
+9% +$174K 0.69% 57
2023
Q3 		$2.07M Buy
26,413
+115
+0.4% +$9.63K 0.68% 57
2023
Q2 		$2.32M Buy
26,298
+228
+0.9% +$19.6K 0.74% 56
2023
Q1 		$2.1M Buy
26,070
+750
+3% +$61.1K 0.7% 56
2022
Q4 		$1.97M Sell
25,320
-812
-3% -$65.8K 0.67% 58
2022
Q3 		$2.11M Buy
26,132
+585
+2% +$52.6K 0.78% 52
2022
Q2 		$2.29M Buy
25,547
+1,580
+7% +$160K 0.77% 53
2022
Q1 		$2.66M Buy
23,967
+227
+1% +$24K 0.77% 53
2021
Q4 		$2.46M Buy
23,740
+1,032
+5% +$120K 0.69% 55
2021
Q3 		$2.85M Sell
22,708
-44
-0.2% -$5.7K 0.87% 49
2021
Q2 		$2.82M Buy
22,752
+55
+0.2% +$6.91K 0.86% 48
2021
Q1 		$2.68M Buy
22,697
+1,010
+5% +$118K 0.88% 45
2020
Q4 		$2.54M Buy
21,687
+216
+1% +$23.8K 0.93% 43
2020
Q3 		$2.23M Buy
21,471
+140
+0.7% +$14.1K 0.96% 41
2020
Q2 		$1.96M Buy
21,331
+2,025
+10% +$194K 0.92% 42
2020
Q1 		$1.74M Buy
19,306
+40
+0.2% +$4.25K 0.96% 42
2019
Q4 		$2.19M Sell
19,266
-215
-1% -$23.6K 0.94% 43
2019
Q3 		$2.12M Sell
19,481
-55
-0.3% -$5.74K 1.35% 32
2019
Q2 		$1.9M Buy
19,536
+595
+3% +$54.3K 1.24% 36
2019
Q1 		$1.73M Buy
18,941
+240
+1% +$21.5K 1.17% 39
2018
Q4 		$1.7M Sell
18,701
-47
-0.3% -$4.39K 1.31% 33
2018
Q3 		$1.84M Sell
18,748
-145
-0.8% -$13.4K 1.29% 33
2018
Q2 		$1.62M Sell
18,893
-125
-0.7% -$10.4K 1.16% 36
2018
Q1 		$1.53M Buy
19,018
+170
+0.9% +$14K 1.13% 38
2017
Q4 		$1.52M Buy
18,848
+468
+3% +$37.5K 1.1% 40
2017
Q3 		$1.43M Buy
18,380
+145
+0.8% +$12K 1.08% 42
2017
Q2 		$1.62M Sell
18,235
-365
-2% -$30.8K 1.28% 33
2017
Q1 		$1.5M Buy
18,600
+23
+0.1% +$1.8K 1.22% 38
2016
Q4 		$1.32M Buy
+18,577
New +$1.46M 1.11% 40

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Concentric Wealth Management's MDT Position: Q3 2024 in Review

Concentric Wealth Management reduced its Medtronic (MDT) stake by 3.6% in Q3 2024, selling an estimated $94.8K and leaving 29,920 shares worth $2.69M. The position accounts for 0.66% of the portfolio, ranked #57.

Concentric Wealth Management first reported a position in MDT in Q4 2016 and has held it in 32 quarters since. The position peaked at $2.85M in Q3 2021. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Concentric Wealth Management held 29,920 shares of Medtronic worth $2.69M as of Q3 2024.
  • Concentric Wealth Management sold 1,127 Medtronic shares in Q3 2024, an estimated $94.8K.
  • Medtronic made up 0.66% of Concentric Wealth Management's portfolio in Q3 2024, its #57 holding.
  • Concentric Wealth Management first reported a position in Medtronic in Q4 2016 and has held it in 32 quarters since.
  • Concentric Wealth Management's Medtronic position peaked at $2.85M in Q3 2021.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.